Concourse Financial Group Securities, Inc. Supernus Pharmaceuticals, Inc. Transaction History

Concourse Financial Group Securities, Inc.

  • $1.67 Billion
  • Q4 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 24 shares of SUPN stock, worth $769. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24
Previous 22 9.09%
Holding current value
$769
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$31.89 - $37.83 $63 - $75
2 Added 9.09%
24 $0
Q3 2024

Oct 10, 2024
SELL
$25.77 - $35.16 $77 - $105
-3 Reduced 12.0%
22 $0
Q2 2024

Jul 23, 2024
SELL
$25.99 - $33.85 $51 - $67
-2 Reduced 7.41%
25 $0
Q1 2024

Apr 30, 2024
BUY
$27.11 - $35.17 $433 - $562
16 Added 145.45%
27 $0
Q4 2023

Feb 07, 2024
SELL
$22.72 - $29.68 $113 - $148
-5 Reduced 31.25%
11 $0
Q3 2023

Oct 25, 2023
SELL
$27.57 - $32.91 $330 - $394
-12 Reduced 42.86%
16 $0
Q2 2023

Aug 10, 2023
SELL
$29.91 - $38.73 $89 - $116
-3 Reduced 9.68%
28 $0
Q4 2022

Jan 30, 2023
BUY
$31.09 - $37.88 $62 - $75
2 Added 6.9%
31 $0
Q3 2022

Nov 15, 2022
BUY
$28.79 - $35.41 $834 - $1,026
29 New
29 $1,000
Q2 2022

Aug 09, 2022
BUY
$25.33 - $34.25 $0 - $0
0 New
0 $0
Q1 2022

May 09, 2022
BUY
$28.51 - $32.9 $0 - $0
0 New
0 $0
Q4 2021

Feb 07, 2022
BUY
$26.37 - $34.22 $0 - $0
0 New
0 $0
Q3 2021

Nov 09, 2021
BUY
$23.54 - $31.39 $0 - $0
0 New
0 $0
Q2 2021

Aug 13, 2021
BUY
$26.72 - $33.19 $0 - $0
0 New
0 $0
Q1 2021

May 13, 2021
BUY
$24.15 - $31.45 $0 - $0
0 New
0 $0
Q4 2020

Feb 02, 2021
BUY
$17.7 - $25.81 $0 - $0
0 New
0 $0
Q3 2020

Nov 13, 2020
BUY
$20.2 - $25.05 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020
BUY
$17.09 - $24.89 $0 - $0
0 New
0 $0
Q1 2020

May 13, 2020
BUY
$14.45 - $24.69 $0 - $0
0 New
0 $0
Q4 2019

Feb 14, 2020
SELL
$19.93 - $29.13 $1,036 - $1,514
-52 Closed
0 $0
Q3 2019

Nov 13, 2019
SELL
$25.47 - $33.37 $713 - $934
-28 Reduced 35.0%
52 $1,000
Q2 2019

Aug 13, 2019
SELL
$29.96 - $38.87 $509 - $660
-17 Reduced 17.53%
80 $3,000
Q1 2019

May 15, 2019
SELL
$32.77 - $41.99 $622 - $797
-19 Reduced 16.38%
97 $3,000
Q4 2018

Feb 14, 2019
BUY
$30.84 - $49.51 $1,233 - $1,980
40 Added 52.63%
116 $3,000
Q3 2018

Nov 13, 2018
BUY
$42.7 - $56.55 $3,245 - $4,297
76 New
76 $4,000

Others Institutions Holding SUPN

# of Institutions
303
Shares Held
60.6M
Call Options Held
22.3K
Put Options Held
6K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.72B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email